IL6 and depressive symptom measurement: In addition, based on two cases of patients with depression after COVID-19, an association between depression and interleukins, including IL-6, was demonstrated independent of other factors, which may justify the administration of cytokine-reducing drugs to prevent depression after COVID-19 [175].